BioSpace News Archive

Genetown

New Entry-Level, Automated Titrators Accelerate Laboratory Productivity

The Thermo Scientific Orion Star T900 Series is designed to automate QC/QA processes and boost efficiency

April 26, 2018
·
3 min read
Pharm Country

BD Launches BD FACSymphony™ S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types

New Cell Sorter Extends BD’s Robust Portfolio of Flow Cytometry Research Solutions

April 26, 2018
·
3 min read
Business

Cipher Pharmaceuticals Proposes Adding Dr. Laurence Terrisse-Rulleau To Board of Directors

Dr. Rulleau is currently a partner at CTI Life Sciences

April 26, 2018
·
2 min read
Business

Bruker Appoints Falko Busse as President of the Bruker BioSpin Group

In his new role, Dr. Busse will have expanded responsibilities and oversight over the BioSpin Group, one of three key Scientific Instruments groups at the Company.

April 26, 2018
·
3 min read
Deals

Vyaire Medical executes on its plan to become a global leader in respiratory care

Acquires Acutronic Medical Systems and agrees to acquire imtmedical

April 26, 2018
·
4 min read
Biotech Bay

Hospital and Commercial Labs to Get Educated on Key Reforms to Order Processing at Executive War College

Veteran lab interoperability company 4medica will advocate its “Perfect Order” approach to reduce diagnostic errors and increase revenue for hospital and commercial outreach labs

April 26, 2018
·
5 min read
Antibe Therapeutics Announces CEO Letter to Shareholders

Letter to stakeholders from Antibe CEO.

April 26, 2018
·
8 min read
FDA

Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration

The new assay will include more than 70 genes and genomic biomarkers for microsatellite instability (MSI) and blood tumor mutational burden (bTMB).

April 26, 2018
·
5 min read
Business

Fujirebio Enters into Agreement with Janssen Pharmaceuticals to Develop and Commercialize AMYLOID β 42/40 RATIO Assay

The Lumipulse® series is intended to help identify patients who may benefit from treatment with Janssen’s new investigational oral BACE inhibitor, atabecestat.

April 26, 2018
·
2 min read
Business

Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018

First-Quarter Revenue of $2.7 Billion Increased 8 Percent on a Reported Basis and 3 Percent on an Operational Basis

April 26, 2018
·
18 min read